Ledger.Open graph →

SEC Form D · Amendment · filed October 7, 2020

BioAegis Therapeutics, Inc

Offering

$7.0M

Sold

$7.0M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

NORTH BRUNSWICK, NJ

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (11)

Mark Dinubile · Morristown, NJExec · Director Susan Levinson · Morristown, NJExec · Director Valerie Ceva · Morristown, NJExec · Director John Stossel · Morristown, NJDirector Ramon A. Pino · Fort Lauderdale, FLExec · Director Brett Harrison · St. Cloud, MNDirector Timothy R. Stinson · El Segundo, CAExec · Director Charles B. Krusen · NEW YORK, NYExec · Director TA Associates SOF II GP, L.P · Boston, MADirector Kelly Lucas · Portland, ORExec · Director Michael Wenzlick · Portland, ORExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗